|
Real-time Estimate
Cboe BZX
16:23:27 14/01/2026 GMT
|
5-day change
|
1st Jan Change
|
|
326.38 USD
|
+0.64%
|
 |
-4.72%
|
-0.55%
|
|
01-13 |
Aligos Therapeutics, Inc. Appoints James Hassard as Executive Vice President and Chief Commercial Officer, Effective January 13, 2026
|
CI
| |
01-12 |
BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer
|
MT
| |
01-12 |
BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer
|
CI
| |
01-12 |
Spyre Therapeutics, Inc. Appoints Kate Tansey Chevlen as Chief Commercial Officer
|
CI
| |
01-08 |
Praxis Precision Medicines, Inc. Announces Management Changes
|
CI
| |
01-07 |
SAB Biotherapeutics, Inc. Announces Board Changes ,Effective January 7, 2026
|
CI
| |
01-07 |
Viking Therapeutics, Inc. Announces Appointment of Neil Aubuchon as Chief Commercial Officer
|
CI
| |
01-02 |
Genelux Corporation Announces Change of Chief Medical Officer
|
CI
| |
01-02 |
Hyphens Pharma International Names Commercial Chief
|
MT
| |
01-01 |
Hyphens Pharma International Limited Appoints Irene Hsu As Chief Commercial Officer, Effective January 2, 2026
|
CI
| |
12-24 |
Dyne Therapeutics, Inc. Announces the Appointment of Vikram Karnani to Its Board of Directors
|
CI
| |
11-24 |
Amgen Insider Sold Shares Worth $1,058,667, According to a Recent SEC Filing
|
MT
| |
11-14 |
Amgen Insider Sold Shares Worth $2,317,071, According to a Recent SEC Filing
|
MT
| |
11-12 |
Autolus Therapeutics plc Appoints Patrick Mcilvenny as Senior Vice President, Finance and Chief Accounting Officer
|
CI
| |
11-12 |
Immix Biopharma, Inc. Appoints Michael Grabow as Chief Commercial Officer
|
CI
| |
11-10 |
Nurix Therapeutics, Inc. Appoints Roger Dansey to Its Board of Directors
|
CI
| |
11-06 |
Coherus Oncology, Inc. Appoints Arvind Sood as Chief Strategy and Corporate Affairs Officer
|
CI
| |
28/10/25 |
Assertio Holdings, Inc. Announces Chief Executive Officer Changes, Effective October 28, 2025
|
CI
| |
27/10/25 |
Agilent Technologies Appoints Adam Elinoff as CFO
|
MT
| |
27/10/25 |
Agilent Technologies, Inc. Announces Executive Changes
|
CI
| |
27/10/25 |
Immatics N.V. Appoints Amie Krause as Chief People Officer, Effective October 27, 2025
|
CI
| |
30/09/25 |
OSE Immunotherapeutics Approves Board Appointments
|
CI
| |
16/09/25 |
Immuneering Corporation Appoints Thomas Schall as Chairman of the Board
|
CI
| |
02/09/25 |
Merck KGaA Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
|
CI
| |
20/08/25 |
Cytokinetics Appoints Jim Daly to Board of Directors and as A Member of Compliance Committee Effective August 19, 2025
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
